Records containing: Scleroderma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-02-20Non-invasive Oxygen-Ozone Therapy in the Treatment of Digital Ulcers in Egyptian Patients With Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2017-10-31A Phase II, Single Centre, Randomised, Placebo-controlled, 3-part Trial to Assess the Safety, Tolerability and Efficacy of Zibotentan in Patients With Renal Disease Secondary to Scleroderma
-
CLINICAL_TRIALS study record update · 2017-10-26Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
-
CLINICAL_TRIALS study record update · 2017-08-29The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard Therapy to Reduce Skin Fibrosis Based on Modified Rodnan Skin Score, Reduce Inflammation, Immunological Response and Fibrosis
-
CLINICAL_TRIALS study record update · 2017-08-09Psychosocial Interventions for Scleroderma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-03-27The Effectiveness of Domperidone Versus Alginic Acid Add on Omeprazole Therapy in Omeprazole Resistance Gastroesophageal Reflux in Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2017-02-10Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
-
CLINICAL_TRIALS study record update · 2016-12-22A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial Assessing the Therapeutic Efficacy of Botulinum Toxin In Treating Scleroderma-Associated Raynaud's Syndrome
-
CLINICAL_TRIALS study record update · 2016-12-22Probiotics in Patients With Moderate-to-severe Distention/ Bloating From Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2016-12-16Endothelial Mircroparticles as a Biomarker of Pulmonary Hypertension in Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2016-08-11ClinicalTrials.gov study NCT02166229
-
CLINICAL_TRIALS study record update · 2016-07-22A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
-
CLINICAL_TRIALS study record update · 2016-05-03The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2016-03-17Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (ADRCs) Registry
-
CLINICAL_TRIALS study record update · 2015-10-22Post Marketing Surveillance Study of Cuprimine (MK-0172-001)
-
CLINICAL_TRIALS study record update · 2015-07-27The Effectiveness of UVA1 Irradiation in the Treatment of Skin Conditions With Altered Dermal Matrix: An Open Pilot Study
-
CLINICAL_TRIALS study record update · 2015-07-10The Effectiveness Of UVA1 Irradiation In The Treatment Of Skin Conditions With Altered Dermal Matrix: A Controlled, Cross-Over Study
-
CLINICAL_TRIALS study record update · 2015-03-05A Phase 1/2 Double Blind, Placebo Controlled, Randomized, Dose Ranging, Repeat Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of CAT-192 Human Anti-TGF-Beta1 Monoclonal Antibody in Patients With Early Stage Diffuse Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2015-02-05Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Healthy Controls
-
CLINICAL_TRIALS study record update · 2014-11-27Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis: a Randomized Double-blind Placebo-controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2014-11-13A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
-
CLINICAL_TRIALS study record update · 2014-11-04Efficacy, Tolerability and Biology of a Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon
-
CLINICAL_TRIALS study record update · 2014-07-02High Dose Cyclophosphamide for Treatment of Systemic Sclerosis (Scleroderma)
-
CLINICAL_TRIALS study record update · 2014-06-26Durometer Skin Assessment in Scleroderma: a Study to Validate This New Tool in the Digital Tufts
-
CLINICAL_TRIALS study record update · 2014-03-17DISTOL-1: Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: A Randomized, Double-blind, Placebo-controlled, Multicenter Study